MATERIAL SAFETY DATA SHEET
PITMAN-MOORE
P.O. Box 207, Terre Haute, IN 47808
(812) 232-012l, 24 Hours
SECTION I: PRODUCT IDENTIFICATION
 
PRODUCT NAME: METOFANE CAS. NO.: 00076-38-0
CHEMICAL FAMILY: Halogenated Ether FORMULA: CH30Cp2CHL2
CHEMICAL NAMES: 2,2—dichloro—l,l—defluroethyl methyl ether,
(methoxyflurane)
DOT CLASSIFICATION: NAl993 Combustible Liquid
SECTION II: COMPOSI ON 5 C S. NO.
  A
2,2—diChlOrO—l,1—deflurOeChyl methyl ether 100 0O76·38-0
SECTION III. PHYSICAL DATA
`
BOILING POINT: 22l‘f
VAPOR PRESSURE, (mm Hg): 23 9 23’
VAPOR DENSITY (Air = l): 4.7
SOLUBILITY IN WATER: Slight
APPEARANCE AND ODOR: Colorless liquid with a fruity odor.
SPECIFIC GRAVITY: 1.4222
EVAPORATION RATE: Approx. 0.33 lbs./hr./sq.ft. @ .70'F.
ODOR THRESHOLD: The odor threshold only serves as a warning of
exposure - not smelling it does not mean you
_ are not being exposed. `
SECTION IV. FIRE AND EXPLQSION HAZARD DATA
FLASH POINT - lOl' TOC UEL - not determined LEL — 7% by volume
EXTINGUISHING MEDIA: Use water fog, foam or liguified gas
extinguishers.
FIREFIGHTING PROCEDURES: Firefighters should wear full protective
clothing and self—contained breathing
apparatus.
SECTION V. REACTIVITY DATA
 
STABILITY: Stable
HAZARDOUS .
DECOMPOSITION PRODUCTS: Toxic gases such as hydrogen chloride and
hydrogen. Fluoride may be released in a fire
involving the product.
INCOMPATIBLES: acid, conc. sulfuric acid and glass above
212'F, 100'C.
HAZARDOUS _
POLYMERIZATION: will not occur.
he information data and recommendations contained herein are believed
to be accurate. Pitman—Moore, Inc. makes no warranty of any kind
whatever with respect thereto and disclaims all liability from reliance
thereon.
- I -

Metofane Page 2 of 3
SECTION VI. HEALTH HAZARD DATA
Permissible Exposure
Limit - NIOSH: The recommended permissible level of exposure
to halogenated anesthetic agents in general is
ZPPM (1978).
ROUTES OF EXPOSURE: Product can enter the body through ingestion or
inhalation.
EFFECTS OF EXPOSURE: Exposure can cause irritation of the eyes,
nose, mouth and throat. overexposure can cause
. unconsciousness, intoxication, dizziness,
death.
Contact may irritate the skin, prolonged
contact may result in blisters. Product is an
anesthetic. Kidneys, Liver and lungs are
target organs of overexposure.
FIRST AID:
EYE CONTACT: Immediately flush with large amounts of tepid
potable water for at least 15 minutes ensuring
inner surfaces of upper and lower lids are
being rinsed. Seek medical attention.
SKIN CONTACT: Remove contaminated clothing. If redness or
irritation results, seek medical attention.
BREATHING: Remove person from exposure. Begin artificial
respiration if breathing has stopped and CPR if
heart action has stopped. Transfer promptly to
a medical facility.
INGESTION:' If product has been swallowed and person is
conscious, immediately administer large amounts
of water and induce vomiting. Begin artificial l
respiration if breathing has stopped and CPR if i
heart action has stopped. Seek medical
attention immediately.
SECTION VII. SPILL LEAK AND DISPOSAL INFORMATION
 
STEPS TO BE
TAKEN IF MATERIAL IS
RELEASED OR SPILLED: Evacuate personnel. Restrict person not
wearing protective equipment from areas of
spills or leaks until cleanup is complete.
Ventilate area of spill or leak. It may be
necessary to contain and dispose of the product
as a hazardous waste. Contact your regional
office of the United States Environmental
Protection Agency (USEPA) for specific
regulations.
SECTION VIII. SPECIAL PROTECTION INFORMATION
 
Wear proper respiratory equipment as product is highly anesthetic. If
‘·aking occurs, transfer to tight container. Where possible, enclose
I erations and use local exhaust ventilation at site of the chemical
release. If local exhaust ventilation or enclosure is not used,
approved respirators should be worn.

Metofane Page 3 of I
SECTION IK. SPECIAL PRECAUTIONS
NOTE TO VETERNARIANS: Caution should be taken to minimize exposure of
hospital personnel to anesthetic gases and
vapors. Evacuation systems and adequate
ventilatlon snould be used to remove waste
gases.
NOTE TO PHYSICIAN: Kidney, liver and lungs are target organs with
overexposure. (See Penthrane in PDR)
a